Lattice Medical
- Industry
- Medical Devices
- Founded Year
- 2017
- Headquarters
- 80 rue du Docteur Yersin, 59120 Loos, France
- Employee Count
- 24
Key People
-
Julien Payen - Co-Founder and CEO
Email: contact@lattice-medical.com
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team, led by CEO Julien Payen, brings over a decade of experience in the MedTech industry.
A leadership team with over 10 years of experience in MedTech suggests a strong foundation for navigating industry challenges and driving product development.
- Clinical Need
-
Aspect: Very Strong
Summary: Lattice Medical addresses a significant unmet need in breast reconstruction post-mastectomy.
With a substantial number of women undergoing mastectomies and limited reconstruction options, Lattice Medical's solutions fulfill a pressing clinical need.
- Competition
-
Aspect: First mover
Summary: Lattice Medical is pioneering in the field of 3D-printed resorbable breast implants.
Introducing innovative products ahead of competitors allows Lattice Medical to set industry standards and capture market share early.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing 3D-printed resorbable implants presents moderate technical challenges.
The integration of 3D printing and biocompatible materials necessitates rigorous testing to ensure safety and efficacy.
- Patent
-
Aspect: Strong
Summary: Lattice Medical holds a strong patent portfolio, including the MATTISSE implant.
Patents protect intellectual property, preventing competitors from replicating innovations and securing market exclusivity.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
Adequate funding ensures resources are available for product development, clinical trials, and commercialization efforts.
- Regulatory
-
Aspect: Pivotal Trial
Summary: Lattice Medical is conducting pivotal trials for its MATTISSE implant.
Successful completion of pivotal trials is a key step toward obtaining regulatory clearance and market entry.
Opportunity Rollup
- Odds of Success
- 3.95
- Peak Market Share
- 5.85
- Segment CAGR
- 6.3%
- Market Segment
- Aesthetic Devices
- Market Sub Segment
- Breast Reconstruction Implants
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.29 |
| 2 | 0.88 |
| 3 | 2.05 |
| 4 | 4.10 |
| 5 | 5.85 |
Key Takeaway
Lattice Medical is well-positioned to address a significant clinical need with its innovative 3D-printed resorbable breast implants, supported by a strong team and financial backing.